Tectonic Therapeutic | AVRO - Zysk Brutto Na Sprzedaży





Zysk Brutto Na Sprzedaży Zmiana Data
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Alnylam Pharmaceuticals USD 829.31M 219.56M 2025-12
Celltrion KRW 626.11B 81.75B 2025-09
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Deva Holding AS TRY 1.32B 235.77M 2023-09
Dianthus Therapeutics USD 284K 112K 2025-12
Divis Laboratories Ltd INR 16.59B 2.05B 2025-12
Gilead Sciences USD 6.31B 106M 2025-12
Ionis Pharmaceuticals USD 195M 40M 2025-12
Kangmei Pharma CNY 270.29M 20.26M 2025-09
Karyopharm Therapeutics USD 32.6M 63.38M 2025-12
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Laboratorios Farma EUR 105.28M 177.08M 2025-06
MacroGenics USD 31.11M 30.14M 2025-12
Medical Developments International AUD 7.35M 7.37M 2025-06
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
Organigram Holdings CAD 23.32M 8.52M 2025-12
Pfizer USD 3.54B 7.61B 2025-09
Pharma Mar EUR 86.7M 53.34M 2025-12
Qiagen NV USD 325.27M 19.53M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Sangamo BioSciences -2.39M 1.09M 2024-06
Sanofi EUR 8.45B 1.31B 2025-12
Sarepta Therapeutics USD 43.55M 204.36M 2025-12
Sartorius EUR 414.5M 18.3M 2026-03
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Takeda JPY 790.55B 262.97B 2025-12
Tilray USD 57.47M 10.16M 2025-06
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zz Pientze Pharmaceu CNY 296.13M 1.1B 2025-06